Cargando…
Development of an oral treatment that rescues gait ataxia and retinal degeneration in a phenotypic mouse model of familial dysautonomia
Familial dysautonomia (FD) is a rare neurodegenerative disease caused by a splicing mutation in elongator acetyltransferase complex subunit 1 (ELP1). This mutation leads to the skipping of exon 20 and a tissue-specific reduction of ELP1, mainly in the central and peripheral nervous systems. FD is a...
Autores principales: | Morini, Elisabetta, Chekuri, Anil, Logan, Emily M., Bolduc, Jessica M., Kirchner, Emily G., Salani, Monica, Krauson, Aram J., Narasimhan, Jana, Gabbeta, Vijayalakshmi, Grover, Shivani, Dakka, Amal, Mollin, Anna, Jung, Stephen P., Zhao, Xin, Zhang, Nanjing, Zhang, Sophie, Arnold, Michael, Woll, Matthew G., Naryshkin, Nikolai A., Weetall, Marla, Slaugenhaupt, Susan A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10027479/ https://www.ncbi.nlm.nih.gov/pubmed/36809767 http://dx.doi.org/10.1016/j.ajhg.2023.01.019 |
Ejemplares similares
-
Selective retinal ganglion cell loss and optic neuropathy in a humanized mouse model of familial dysautonomia
por: Chekuri, Anil, et al.
Publicado: (2021) -
A deep learning approach to identify gene targets of a therapeutic for human splicing disorders
por: Gao, Dadi, et al.
Publicado: (2021) -
Reduction of retinal ganglion cell death in mouse models of familial dysautonomia using AAV-mediated gene therapy and splicing modulators
por: Schultz, Anastasia, et al.
Publicado: (2023) -
Small molecule splicing modifiers with systemic HTT-lowering activity
por: Bhattacharyya, Anuradha, et al.
Publicado: (2021) -
COVID-19-Associated Dysautonomia
por: Suresh, Krithika, et al.
Publicado: (2021)